Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications

John Greene1, Ashvina Segaran2, Simon Lord1

  • 1Department of Oncology, University of Oxford, Churchill Hospital, Oxford, United Kingdom.

Insights

Oxidative phosphorylation (OXPHOS) is crucial for cancer cell energy and growth, contrary to previous beliefs. Targeting OXPHOS and the electron transport chain presents a promising avenue for novel cancer therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Mitochondria generate ATP through oxidative phosphorylation (OXPHOS) using fuels and oxygen.
  • Historically, glycolysis was considered the primary ATP source in tumors, with OXPHOS thought to be reduced.
  • Emerging evidence highlights OXPHOS's critical role in meeting cancer cells' bioenergetic and anabolic demands.

Purpose of the Study:

  • To review the current understanding of OXPHOS in cancer.
  • To discuss therapeutic strategies targeting OXPHOS and the electron transport chain.
  • To identify challenges in developing OXPHOS-targeted cancer therapies.

Main Methods:

  • Literature review of studies on OXPHOS in cancer.
  • Analysis of current therapeutic approaches targeting OXPHOS.
  • Discussion of the challenges and future directions in the field.

Main Results:

  • OXPHOS is essential for the bioenergetic and macromolecular needs of many cancer types.
  • Targeting OXPHOS and the electron transport chain is a growing area of cancer therapy research.
  • Significant challenges remain in developing effective and safe OXPHOS-targeted cancer treatments.

Conclusions:

  • OXPHOS plays a vital role in cancer cell metabolism and survival.
  • Targeting OXPHOS offers a promising strategy for cancer treatment.
  • Further research is needed to overcome challenges and optimize OXPHOS-based cancer therapies.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K